Norgestimate: A clinical overview of a new progestin

This publication has 48 references indexed in Scilit:

• Regression of atherosclerotic lesions by high density lipoprotein plasma fraction in the cholesterol-fed rabbit.
  Journal of Clinical Investigation, 1990
• Oral contraceptives and lipids.
  BMJ, 1989
• The Reduction in Risk of Ovarian Cancer Associated with Oral-Contraceptive Use
  New England Journal of Medicine, 1987
• Licht- und elektronenmikroskopische Veränderungen des Endometriums unter Einnahme eines norgestimathaltigen oralen Kontrazeptivums (Cilest®)
  Geburtshilfe und Frauenheilkunde, 1986
• The triglyceride issue: A view from Framingham
  American Heart Journal, 1986
• Effects of norgestimate (0.250 mg) in combination with ethinyl estradiol (0.035 mg) on cervical mucus
  Advances in Contraception, 1986
• Effect of Estrogen/Progestin Potency on Lipid/Lipoprotein Cholesterol
  New England Journal of Medicine, 1983
• Influence of human low density and high density lipoprotein cholesterol on the in vitro prostaglandin I2 synthetase activity
  Biochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism, 1980
• High Density Lipoproteins and Atherosclerosis
  Annual Review of Medicine, 1980
• Disposition of Norgestimate in the Presence and Absence of Ethinyl Estradiol after Oral Administration to Humans
  Journal of Pharmaceutical Sciences, 1978